Early safety indicators of COVID-19 convalescent plasma in 5000 patients

Michael J. Joyner(Mayo Clinic), Arturo Casadevall(Johns Hopkins University), Chad C. Wiggins(Johns Hopkins University), Andrew J. Clayburn(Johns Hopkins University), Elizabeth R. Lesser(Mayo Clinic), Camille M. van Buskirk(Johns Hopkins University), Stephen A. Klassen(Johns Hopkins University), Allan M. Klompas(Johns Hopkins University), Rickey E. Carter(Mayo Clinic in Florida), Katelyn A. Bruno(Mayo Clinic in Florida), Emily R. Whelan(Mayo Clinic in Florida), John R.A. Shepherd(Johns Hopkins University), Kylie J. Andersen(Johns Hopkins University), James R. Stubbs(Johns Hopkins University), Jeffrey L. Winters(Mayo Clinic in Arizona), Janis E. Blair(NorthShore University HealthSystem), Philippe R. Bauer(Mayo Clinic in Florida), Jonathon W. Senefeld(Mayo Clinic), Robert F. Rea(Harvard–MIT Division of Health Sciences and Technology), Vitaly Herasevich(Mayo Clinic in Florida), Katie L. Kunze(Mayo Clinic in Arizona), R. Scott Wright(Mayo Clinic in Arizona), Patrick W. Johnson(Mayo Clinic in Florida), Matthew R. Spiegel(Mayo Clinic in Florida), Kathryn F. Larson(Johns Hopkins University), Sarah E. Baker(Johns Hopkins University), Juan G. Ripoll(Johns Hopkins University), Nicole Verdun(Center for Biologics Evaluation and Research), Riley J. Regimbal(Johns Hopkins University), Nigel Paneth, DeLisa Fairweather(Johns Hopkins University), David O. Hodge(Allegheny College), Matthew Buras, Peter Marks(Johns Hopkins University), Joshua J. Dennis(Johns Hopkins University), Matthew N.P. Vogt(Johns Hopkins University)
Journal of Clinical Investigation
June 11, 2020
Cited by 485


Related Papers